Home » Stocks » MDNA

Medicenna Therapeutics Corp. (MDNA)

Stock Price: $4.38 USD -0.02 (-0.45%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
After-hours: $4.51 +0.13 (2.97%) Jan 21, 7:59 PM
Market Cap 219.70M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 48.85M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $4.38
Previous Close $4.40
Change ($) -0.02
Change (%) -0.45%
Day's Open 4.56
Day's Range 4.34 - 4.62
Day's Volume 470,250
52-Week Range 3.55 - 5.97

News

There are no news available yet.

About MDNA

Medicenna Therapeutics, a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and non-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat... [Read more...]

Industry
Biotechnology
CEO
Dr. Fahar Merchant
Employees
7
Stock Exchange
NASDAQ
Ticker Symbol
MDNA
Full Company Profile

Financial Performance

Financial Statements